Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.
about
Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic SystemThe Role of Toll-Like Receptor 4 in Infectious and Noninfectious InflammationEmerging preclinical pharmacological targets for Parkinson's diseaseReview: Multiple system atrophy: emerging targets for interventional therapiesNeuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein AggregationInnate Immune Response in Brain, NF-Kappa B Signaling and CystatinsImmunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein AggregationNeuroinflammation in Parkinson's disease and its potential as therapeutic targetGlia and alpha-synuclein in neurodegeneration: A complex interactionThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's diseaseThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?M1 and M2 immune activation in Parkinson's Disease: Foe and ally?Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neuronsSeeking a mechanism for the toxicity of oligomeric α-synucleinAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyNLRP3 Inflammasome in Neurological Diseases, from Functions to TherapiesIntramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.Phagocytosis of microglia in the central nervous system diseasesHeat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease.New insights on NOX enzymes in the central nervous system.Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.Towards translational therapies for multiple system atrophyAbrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats.Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathySpinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterizationMicroglial activation mediates host neuronal survival induced by neural stem cells.Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.The role of Galectin-3 in α-synuclein-induced microglial activation.Exploring Braak's Hypothesis of Parkinson's Disease.Sequence-dependent internalization of aggregating peptidesCentral pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression.Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease.Immune aging, dysmetabolism, and inflammation in neurological diseases.Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes.The Interplay between Alpha-Synuclein Clearance and SpreadingAutophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical ImplicationsInduction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson's disease
P2860
Q24622752-08174F30-1691-4164-8D31-974371233807Q26738336-9C79842D-4D46-4373-9A5A-542F428EB96BQ26747005-0D07ED58-1CED-4465-9FA5-3F5F44D84CFFQ26764724-F525E34D-D6FC-4A1A-A4BB-56BE3A46707DQ26770919-67E6CEF7-1A24-4BE8-A0E0-0EFB52528058Q26771536-C12D0DCC-F96A-4B30-BADF-2DDE05F0D8D3Q26773162-CE9F1FD2-2998-4C84-9831-C05FF98841C1Q26781130-01B8ED7C-6741-4DBB-ACB5-C3EA951A0E49Q26783305-0175D310-3CF7-4975-9C24-CE7900215BE5Q26851153-001C1749-0287-4663-819E-D362071E12C9Q26853537-C117CB65-BAFE-4B43-BA28-F6178D232CE8Q26861263-FA78FD25-20BC-4C9B-BF1E-427321EFD81FQ27024667-942199EF-EB4B-4E96-A5C2-B21BDDF45B90Q27301082-88642ED8-8933-4BE7-815B-1CD4F5022477Q28080551-6A1F6D72-0528-4A78-A30C-C547A592D7E1Q28395248-CDC5F5CF-4E69-4C03-95B6-D6DA1B4A6B55Q29248417-BA3D8DB5-F678-42C0-AFF3-B681B42D38BCQ30585365-222023BE-C006-4722-8C18-FEAE4C3A2610Q33574527-B3DA1FF1-CB36-4B2E-AD78-06CAE40ABB14Q33602136-1943105B-33F1-4CBA-92C8-82570AC7AB19Q33632673-695A84AB-AF4C-42DE-96F4-11EA72DC12BEQ33727623-CDAECA5C-3636-4A09-81D9-BE95AE156316Q33797532-7FD44546-DB99-45C5-87E3-27102734FB2FQ33835006-572A4047-4425-4FD7-B55E-43928F6C94D9Q33868678-09D60ABE-5D10-4B39-8554-A211298F3D26Q33897359-8E1594F8-30B6-4D84-9188-1C9049DC8166Q34011453-18B3F720-6BBA-44B2-99A3-9E7FE682402CQ34481921-79597EC8-3D29-48FC-8F1D-46E802A5018CQ34537231-B1DBAA77-5A33-4091-B5B2-13C375BF126DQ34552244-9F22724D-8813-4573-880A-31EF6EFF28BFQ34801378-02F6FA23-B5AE-46FB-848E-AEACEA6B1F36Q35059951-DF3CA4C8-9DF1-42C7-BE37-DD347668F0B3Q35063989-2B1216FC-5265-429F-A301-711D40B6664DQ35609611-A913267F-9276-43D0-9BC1-1BB638E29B3DQ35677347-6EBD1ABA-4348-4E89-9569-8980D1F83E81Q35766124-A141F72D-2657-45C6-84EB-2EAEFB3EA5C9Q35833984-923C8344-1BF3-4A4F-8046-B916626AE2E1Q35853020-5F68BEE1-948B-491E-8A8C-788A8E0BBA36Q35952063-A26A1BF1-D091-4EDB-96ED-16F0550E4FCFQ36123393-64CD40B1-0737-4422-8FCE-7A4BBF922C95
P2860
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Toll-like receptor 4 is requir ...... on of microglia and astroglia.
@en
type
label
Toll-like receptor 4 is requir ...... on of microglia and astroglia.
@en
prefLabel
Toll-like receptor 4 is requir ...... on of microglia and astroglia.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Toll-like receptor 4 is requir ...... ion of microglia and astroglia
@en
P2093
Kathrin Schanda
Lisa Fellner
Werner Poewe
P2860
P304
P356
10.1002/GLIA.22437
P577
2012-10-25T00:00:00Z